People with type 2 diabetes who use semaglutide drugs like Ozempic and Wegovy appear to have a lower risk of Alzheimer's ...
Novo Nordisk has asked the FDA to block production of compounded copies of Ozempic, arguing that it’s too difficult to do ...
When you're taking GLP-1 medications for weight loss, it's easy for nutrition to get overlooked because while semaglutide ...
The agency posted documents this week that the drugmaker had requested the drug be placed on the FDA's "Demonstrable ...
As previously reported in Women’s Health, semaglutide injections mimic the effects of a hormone called glucagon-like ...
Ozempic maker Novo Nordisk (NVO) is asking the U.S. Food and Drug Administration (FDA) to prohibit compounding pharmacies ...